Seer Medical, a Melbourne, Australia-based company specializing in home-based epilepsy diagnostics, received an investment from Caldwell.
The amount of the deal was not disclosed.
The company intends to use the funds to integrate its long-term home EEG technology with Cadwell’s existing comprehensive EEG portfolio.
Founded in 2017, Seer Medical leverages cloud, web, and AI technologies along with a patient-centric design to advance epilepsy care in the field of neurology. Their flagship product, Seer Home, is focused on long-term home-based video electroencephalography (EEG) monitoring, a technology system that measures the brain’s electrical activity to accelerate epilepsy detection, without the need for hospitalization.
The investment also provided Cadwell with access to Seer Medical’s Melbourne office and staff, enhancing its technical breadth and capacity for bringing new products to market.
FinSMEs
15/04/2025